CN112603957A - Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof - Google Patents
Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof Download PDFInfo
- Publication number
- CN112603957A CN112603957A CN202110034417.XA CN202110034417A CN112603957A CN 112603957 A CN112603957 A CN 112603957A CN 202110034417 A CN202110034417 A CN 202110034417A CN 112603957 A CN112603957 A CN 112603957A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- rhizome
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 105
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims description 17
- 229940079593 drug Drugs 0.000 claims abstract description 34
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 29
- 239000004863 Frankincense Substances 0.000 claims abstract description 29
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 21
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 claims abstract description 21
- 244000018716 Impatiens biflora Species 0.000 claims abstract description 21
- 235000015912 Impatiens biflora Nutrition 0.000 claims abstract description 21
- 244000107975 Strychnos nux-vomica Species 0.000 claims abstract description 21
- 235000005155 Tanacetum balsamita Nutrition 0.000 claims abstract description 21
- 229940116229 borneol Drugs 0.000 claims abstract description 21
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 21
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 20
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 20
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 20
- 241000725145 Homalomena Species 0.000 claims abstract description 20
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 claims abstract description 20
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 20
- 244000195896 dadap Species 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 18
- 241000218158 Clematis Species 0.000 claims abstract description 13
- 244000241463 Cullen corylifolium Species 0.000 claims abstract description 10
- 241001660870 Cyrtomium Species 0.000 claims abstract description 10
- 241000212322 Levisticum officinale Species 0.000 claims abstract description 10
- 241000218206 Ranunculus Species 0.000 claims abstract description 10
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 10
- 239000001645 levisticum officinale Substances 0.000 claims abstract description 10
- 244000089698 Zanthoxylum simulans Species 0.000 claims abstract description 7
- 235000009932 Zanthoxylum simulans Nutrition 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 53
- 238000003756 stirring Methods 0.000 claims description 39
- 238000002156 mixing Methods 0.000 claims description 37
- 239000002994 raw material Substances 0.000 claims description 32
- 239000000843 powder Substances 0.000 claims description 24
- 238000005303 weighing Methods 0.000 claims description 22
- 238000007789 sealing Methods 0.000 claims description 21
- 238000010298 pulverizing process Methods 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 9
- 239000012535 impurity Substances 0.000 claims description 9
- 238000012216 screening Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 235000007650 Aralia spinosa Nutrition 0.000 claims description 6
- 241000949456 Zanthoxylum Species 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 3
- 244000089795 Clausena lansium Species 0.000 claims description 2
- 235000008738 Clausena lansium Nutrition 0.000 claims description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 41
- 230000000694 effects Effects 0.000 abstract description 37
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 241000903946 Clematidis Species 0.000 description 16
- 230000008961 swelling Effects 0.000 description 16
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 230000001717 pathogenic effect Effects 0.000 description 13
- 210000000988 bone and bone Anatomy 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 12
- 210000002435 tendon Anatomy 0.000 description 12
- 208000006820 Arthralgia Diseases 0.000 description 11
- 241001226187 Cyrtomium fortunei Species 0.000 description 11
- 235000008184 Piper nigrum Nutrition 0.000 description 11
- 241000112528 Ligusticum striatum Species 0.000 description 10
- 230000003213 activating effect Effects 0.000 description 10
- 241000717739 Boswellia sacra Species 0.000 description 9
- 241000722363 Piper Species 0.000 description 9
- 241001604597 Pyrestini Species 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 235000002566 Capsicum Nutrition 0.000 description 8
- 244000153234 Hibiscus abelmoschus Species 0.000 description 8
- 239000006002 Pepper Substances 0.000 description 8
- 235000016761 Piper aduncum Nutrition 0.000 description 8
- 235000017804 Piper guineense Nutrition 0.000 description 8
- 208000005392 Spasm Diseases 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 8
- 210000000582 semen Anatomy 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 6
- 230000003467 diminishing effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 241000721047 Danaus plexippus Species 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 206010020718 hyperplasia Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 244000203593 Piper nigrum Species 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 208000034783 hypoesthesia Diseases 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000001503 joint Anatomy 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 208000004371 toothache Diseases 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010057178 Osteoarthropathies Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 201000010934 exostosis Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 201000010930 hyperostosis Diseases 0.000 description 2
- 230000002390 hyperplastic effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 241001092090 Pittosporum Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 240000004429 Tephrosia purpurea Species 0.000 description 1
- 235000017517 Tephrosia purpurea Nutrition 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010047631 Vitamin E deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000002078 massotherapy Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine for treating hyperosteogeny, and relates to the technical field of traditional Chinese medicines. The traditional Chinese medicine for treating the hyperosteogeny is prepared from the following raw medicines in parts by weight: 50-70 parts of clematis root, 20-30 parts of divaricate saposhnikovia root, 20-30 parts of borneol, 30-40 parts of szechuan lovage rhizome, 10-25 parts of ternate buttercup root, 20-30 parts of erythrina bark, 25-40 parts of cyrtomium rhizome, 10-30 parts of garden balsam stem, 10-15 parts of Sichuan pepper, 40-50 parts of artificial musk, 20-35 parts of raw nux vomica, 40-50 parts of malaytea scurfpea fruit, 30-40 parts of obscured homalomena rhizome, 15-35 parts of frankincense and 200 parts of white spirit 140 and other materials. The components in the traditional Chinese medicine formula prepared by the invention are mutually cooperated and play a role together, so that the prepared traditional Chinese medicine can relieve pain and has a better treatment effect, and the components used in the formula are all relatively cheap medicinal materials, so that the treatment expense of a patient can be reduced.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine for treating hyperosteogeny and a preparation method thereof.
Background
In the modern society, the rhythm of life is fast, and people are under tension and pressure, so that proliferative osteoarthropathy such as neck, shoulder, waist, leg and the like becomes common diseases, and the proliferative osteoarthropathy is also called as hyperosteogeny. Hyperosteogeny is a common frequently-occurring disease in clinic, mainly because the long-term abrasion of joints causes the hyperplasia and traction of ligaments around the joints, and normal sclerotin around the joints is gradually increased. It is also called hyperplasia, hypertrophic or degenerative arthritis, and refers to chronic arthropathy caused by the destruction of joint cartilage due to joint degeneration. The disease is better at cervical vertebra, lumbar vertebra, hip, knee, and root bone, and can occur singly or frequently.
The pathogenic factors of this disease are usually the accumulation of blood stasis and the accumulation of pathogen without dispersing, and are usually caused by liver and kidney deficiency, essence and blood deficiency or wind-cold-dampness pathogen entering due to deficiency, qi-blood obstruction, and malnutrition of muscles and bones. The existing common means are (1) surgical excision, the pain of a patient is large, the cost is high, the wound of the affected joint is large, and hyperosteogeny is formed in the process of wound repair; (2) the medical treatment course is long, and the treatment is temporary and permanent; (3) the massage or physical therapy is painful and ineffective for the patient. Therefore, a treatment means with less pain, low cost and good treatment effect is urgently needed.
Disclosure of Invention
The invention aims to provide the traditional Chinese medicine for treating the hyperosteogeny, and the traditional Chinese medicine for treating the hyperosteogeny has the advantages of small pain, low cost and good treatment effect.
The invention also aims to provide a preparation method of the traditional Chinese medicine for treating the hyperosteogeny so as to obtain the traditional Chinese medicine for treating the hyperosteogeny with good treatment effect.
The technical problem to be solved by the invention is realized by adopting the following technical scheme.
On one hand, the embodiment of the application provides a traditional Chinese medicine for treating hyperosteogeny, which is prepared from the following raw material medicines in parts by weight: 50-70 parts of clematis root, 20-30 parts of divaricate saposhnikovia root, 20-30 parts of borneol, 30-40 parts of szechuan lovage rhizome, 10-25 parts of ternate buttercup root, 20-30 parts of erythrina bark, 25-40 parts of cyrtomium rhizome, 10-30 parts of garden balsam stem, 10-15 parts of Sichuan pepper, 40-50 parts of artificial musk, 20-35 parts of raw nux vomica, 40-50 parts of malaytea scurfpea fruit, 30-40 parts of obscured homalomena rhizome, 15-35 parts of frankincense and 200 parts of white spirit 140 and other materials.
On the other hand, the embodiment of the application also provides a preparation method of the traditional Chinese medicine for treating the hyperosteogeny, which specifically comprises the following steps:
weighing the medicines: weighing the raw material medicines according to the proportion of the formula;
crushing: pulverizing the raw materials except Chinese liquor to obtain raw medicinal powder;
mixing: mixing the raw material powder obtained in the crushing step with the white spirit, and uniformly stirring to obtain a mixture;
sealing: placing the mixture prepared in the mixing step in a closed container for sealed storage;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
The clematis root is pungent, salty and warm in taste, has the functions of entering bladder channel, dispelling wind and removing dampness, and dredging collaterals and relieving pain, and is used for treating rheumatic arthralgia, numbness of limbs, spasm of muscles and vessels, difficulty in flexion and extension, and choking throat.
Radix Saposhnikoviae is pungent, sweet and warm in flavor, has effects of entering bladder, liver and spleen channels, relieving exterior syndrome, dispelling pathogenic wind, eliminating dampness, and relieving spasm, and can be used for treating common cold, headache, rheumatalgia, rubella pruritus, and tetanus.
Borneol is bitter in taste and cool, has the effects of dredging orifices, dispelling stagnated fire, removing nebula and improving eyesight, and relieving swelling and pain. It is a commonly used skin penetration enhancer for treating vomiting due to apoplexy, coma due to febrile disease, epilepsy due to convulsion, phlegm coma, qi block, deafness, pharyngitis, aphtha, otitis media, carbuncle, swelling, hemorrhoid, nebula and enterobiasis.
Rhizoma Ligustici Chuanxiong has effects of promoting blood circulation, activating qi-flowing, dispelling pathogenic wind and relieving pain, contains an oily alkaloid, ferulic acid volatile oil, etc. and can paralyze nerve center, so has effects of relieving pain, relieving spasm and tranquilizing; it also has vitamin E deficiency resisting effect, and can soften hyperplastic bone.
Radix Ranunculi Ternati has effects of removing toxic substance, eliminating phlegm and resolving hard mass, and relieving swelling, and can be used for treating lymphoid tuberculosis, pharyngitis, furuncle, snake bite, malaria, migraine, and toothache.
Cortex Erythrinae has effects of relieving pain, diminishing inflammation, dispelling pathogenic wind, activating qi-flowing, eliminating dampness, and promoting blood circulation, and can be used for treating gastritis, nephritis and rheumatalgia, or for treating knife wound by external application; expelling wind-damp, dredging channels and collaterals, and killing parasites; it is indicated for wind-damp arthralgia, dysentery, toothache, scabies and tinea.
Cyrtomium fortunei, being slightly cold in nature and bitter in taste, enters liver and stomach meridians, and is used for clearing away heat and toxic material, killing parasites and stopping bleeding, belonging to the category of heat-clearing and detoxifying drugs.
The garden balsam stem is pungent in taste and warm in nature, has the effects of dispelling pathogenic wind, removing dampness, relieving rigidity of muscles, promoting blood circulation, removing blood stasis, relieving swelling, removing toxic substance and relieving eye pain, and can be used for treating rheumatalgia, tendons and bones contracture, cold dampness loempe, waist sprain, paralysis, amenorrhea, eczema of scrotum, skin ulcer, furuncle, and pyogenic infections.
The Sichuan pepper is pungent in flavor, warm, hot, toxic, pathogenic qi cough, middle-jiao warming, bone joint and skin dead muscle removing, cold-dampness arthralgia, qi descending, six fu-organ cold removing, typhoid fever, malaria, strong wind and sweat, retained food in the heart and abdomen, intestinal diarrhea, essence excretion, female chronic breast disease, pathogenic wind dispersing, abdominal mass, edema, yellow gall, chronic fever, and toxic parasites killing and fish poison. If the medicine is taken for a long time, the head is not white, and the body is lightened and the life is prolonged. It can be used as plaster for opening striae, promoting blood circulation, strengthening teeth and hair, regulating joint function, and resisting cold and summer heat.
The peel is pungent and warm in flavor. Has little toxicity. Has effects in expelling pathogenic wind, dispelling cold, removing toxic materials, and relieving pain. Can be used for treating rheumatism, osteodynia, traumatic injury, toothache, and venomous snake bite.
Artificial musk is pungent in flavor and warm in nature, enters heart and spleen channels, has the functions of inducing resuscitation and refreshing mind, and is capable of activating blood and resolving masses, and inducing parturition and getting fetus down. Can remove blood stasis, has the functions of promoting blood circulation to disperse stagnation, and relieving swelling and pain, and is often combined with toxicity-removing and blood-activating herbs to be taken orally or externally applied to sore and furuncle pyogenic infections; it can be used for amenorrhea, traumatic injury and arthralgia, and is combined with blood-activating and stasis-resolving herbs to strengthen its blood-activating action.
The unprocessed Strychnos nux-vomica has cold nature, bitter taste and toxicity, enters liver and spleen channels, has the effects of dissipating stagnation, reducing swelling, dredging collaterals and relieving pain, and is traditionally used for treating rheumatism, obstinate paralysis, gangrene, carbuncle, gall, traumatic injury and the like.
Fructus Psoraleae has effects of invigorating bone, tonifying yang, warming spleen and relieving diarrhea, and can be used for treating symptoms such as nocturnal emission, urination reduction, kidney yin deficiency, and psychroalgia of waist and knee.
Rhizoma homalomenae has effects of dispelling pathogenic wind, removing dampness, and strengthening tendons and bones, and can be used for treating rheumatism, arthralgia and myalgia, and spasm and numbness.
Olibanum has effects in promoting blood circulation and relieving pain, and can be used for treating blood stasis, swelling and pain, spasm of tendons and collaterals, and spasm of tendons and collaterals due to arthralgia-deep-rooted carbuncle; the milk is fragrant, bitter, pungent and warm in nature, so it can dredge tendons and vessels, activate and relieve swelling and stasis, stop pain, relieve spasm and extension of tendons, relieve swelling and pain, and promote granulation.
Compared with the prior art, the embodiment of the invention has at least the following advantages or beneficial effects:
(1) the formula adopted by the invention is a traditional Chinese medicine for treating hyperosteogeny with outstanding effect obtained by the inventor through years of research and development and experiments and continuously improving the formula after long-time experiment comparative analysis, all components in the formula are mutually cooperated and play a role together, so that the prepared traditional Chinese medicine can relieve pain and has better treatment effect, and the components used in the adopted formula belong to cheaper medicinal materials, thereby simultaneously reducing the treatment expense of patients.
(2) The traditional Chinese medicine composition is scientific in composition, reasonable in compatibility and synergistic in synergy of all components according to the monarch, minister, assistant and guide principles, specifically takes clematis root, ligusticum wallichii, cyrtomium fortunei, radix ranunculi ternati, erythrina bark, garden balsam stem and fructus psoraleae as monarch drugs, plays roles of dispelling wind and removing dampness, dredging collaterals and relieving pain, relieving pain and spasm and calming, diminishing inflammation, promoting qi and activating blood, tonifying bone and tonifying yang, warming spleen and stopping diarrhea, and can be used for treating symptoms due to the fact that blood stasis and pathogen of a patient are mixed and coagulated without dispersion and damp-heat swelling; borneol, pricklyash peel, artificial musk and obscured homalomena rhizome are taken as ministerial drugs, so that the effects of relieving swelling and pain, eliminating cold-dampness and arthralgia, dispelling wind-damp and strengthening tendons and bones are achieved, and the hyperosteogeny is better treated; the raw nux vomica and the divaricate saposhnikovia root are taken as adjuvant drugs, so that the effects of eliminating rheumatism and arthralgia, eliminating stagnation and reducing swelling, and dredging collaterals and relieving pain are achieved, and the treatment effect is enhanced; the liquor and the frankincense are used as guiding drugs, and the effects of dredging the tendons and vessels, activating and diminishing swelling, removing blood stasis, and dredging the channels and activating the collaterals are achieved. The medicines are matched and supplemented with each other to achieve the effects of promoting blood circulation and promoting qi circulation, removing blood stasis and relieving pain, stretching tendons and activating collaterals, dredging collaterals and removing blood stasis and relieving pain, and dispelling internal cold and dampness to soften the bony spur, so that the hyperosteogeny is softened and the pain is relieved.
(3) The traditional Chinese medicine composition is scientific in composition, reasonable in compatibility and synergistic in synergy of all components according to the monarch, minister, assistant and guide principles, specifically takes clematis root, ligusticum wallichii, cyrtomium fortunei, radix ranunculi ternati, erythrina bark, pittosporum root, garden balsam stem and fructus psoraleae as monarch drugs, plays roles of dispelling wind and removing dampness, dredging collaterals and relieving pain, relieving pain and spasm and calming, diminishing inflammation, promoting qi and blood circulation, tonifying bones and strengthening yang, warming spleen and stopping diarrhea, and detoxifying and relieving pain, and can be used for treating symptoms by compounding the drugs due to the fact that stasis and pathogen are mixed and coagulated but not dispersed, and damp; borneol, pricklyash peel, artificial musk and obscured homalomena rhizome are taken as ministerial drugs, so that the effects of relieving swelling and pain, eliminating cold-dampness and arthralgia, dispelling wind-damp and strengthening tendons and bones are achieved, and the hyperosteogeny is better treated; the raw nux vomica and the divaricate saposhnikovia root are taken as adjuvant drugs, so that the effects of eliminating rheumatism and arthralgia, eliminating stagnation and reducing swelling, and dredging collaterals and relieving pain are achieved, and the treatment effect is enhanced; the liquor and the frankincense are used as guiding drugs, and the effects of dredging the tendons and vessels, activating and diminishing swelling, removing blood stasis, and dredging the channels and activating the collaterals are achieved. The medicines are matched and supplemented with each other to achieve the effects of promoting blood circulation and promoting qi circulation, removing blood stasis and relieving pain, stretching tendons and activating collaterals, dredging collaterals and removing blood stasis and relieving pain, and dispelling internal cold and dampness to soften the bony spur, so that the hyperosteogeny is softened and the pain is relieved.
(4) The liquor is mixed with other medicinal materials for soaking, and after the soaking time is reached, the drug effects of various traditional Chinese medicines are mixed into the liquor, so that the liquor contains certain drug effect components, and better permeates into human body to achieve the treatment effect.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
The invention provides a traditional Chinese medicine for treating hyperosteogeny, which is prepared from the following raw medicines in parts by weight: 50-70 parts of clematis root, 20-30 parts of divaricate saposhnikovia root, 20-30 parts of borneol, 30-40 parts of szechuan lovage rhizome, 10-25 parts of ternate buttercup root, 20-30 parts of erythrina bark, 25-40 parts of cyrtomium rhizome, 10-30 parts of garden balsam stem, 10-15 parts of Sichuan pepper, 40-50 parts of artificial musk, 20-35 parts of raw nux vomica, 40-50 parts of malaytea scurfpea fruit, 30-40 parts of obscured homalomena rhizome, 15-35 parts of frankincense and 200 parts of white spirit 140 and other materials.
In detail, the traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 60 parts of clematis root, 30 parts of divaricate saposhnikovia root, 22 parts of borneol, 36 parts of szechuan lovage rhizome, 20 parts of ternate buttercup root, 25 parts of erythrina bark, 30 parts of cyrtomium rhizome, 23 parts of garden balsam stem, 12 parts of pricklyash peel, 43 parts of artificial musk, 28 parts of raw nux vomica, 46 parts of malaytea scurfpea fruit, 38 parts of obscured homalomena rhizome, 25 parts of frankincense and 160 parts of white spirit.
In detail, the traditional Chinese medicine is prepared from the following raw materials in parts by weight: 50-70 parts of clematis root, 20-30 parts of divaricate saposhnikovia root, 20-30 parts of borneol, 30-40 parts of szechuan lovage rhizome, 10-25 parts of ternate buttercup root, 20-30 parts of erythrina bark, 25-40 parts of cyrtomium rhizome, 10-30 parts of garden balsam stem, 10-15 parts of Sichuan pepper, 10-30 parts of seed of Chinese wampee, 40-50 parts of artificial musk, 20-35 parts of raw nux vomica, 40-50 parts of malaytea scurfpea fruit, 30-40 parts of obscured homalomena rhizome, 15-35 parts of frankincense and 200 parts of white spirit.
In detail, the traditional Chinese medicine is prepared from the following raw materials in parts by weight: 60 parts of clematis root, 30 parts of divaricate saposhnikovia root, 22 parts of borneol, 36 parts of szechuan lovage rhizome, 20 parts of ternate buttercup root, 25 parts of erythrina bark, 30 parts of cyrtomium rhizome, 23 parts of garden balsam stem, 12 parts of pricklyash peel, 25 parts of seed of Chinese yam, 43 parts of artificial musk, 28 parts of raw nux vomica, 46 parts of malaytea scurfpea fruit, 38 parts of obscured homalomena rhizome, 25 parts of frankincense and 160 parts of white.
In detail, the white spirit is 60-65 degree white spirit.
The invention also provides a preparation method of the traditional Chinese medicine for treating hyperosteogeny, which comprises the following steps:
weighing the medicines: weighing the raw material medicines according to the proportion of the formula;
crushing: pulverizing the raw materials except Chinese liquor to obtain raw medicinal powder;
mixing: mixing the raw material powder obtained in the crushing step with the white spirit, and uniformly stirring to obtain a mixture;
sealing: placing the mixture prepared in the mixing step in a closed container for sealed storage;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
In detail, the size of the raw medicinal powder crushed in the crushing step is 80-200 meshes.
In detail, the stirring speed of the mixing step is 70-80r/min, and the stirring time is 10-30 min.
In detail, the sealing step is to seal and store the mixture in a closed container for 3 months, open the container every 1 month, and stir the mixture in the container at a speed of 70-80r/min for 1-5 min.
The features and properties of the present invention are described in further detail below with reference to examples.
Example 1
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 50g of radix clematidis, 20g of divaricate saposhnikovia root, 20g of borneol, 30g of ligusticum wallichii, 10g of radix ranunculi ternati, 20g of erythrina bark, 25g of cyrtomium fortunei, 10g of garden balsam stem, 10g of pepper, 40g of artificial musk, 20g of raw nux vomica, 40g of fructus psoraleae, 30g of obscured homalomena rhizome, 15g of frankincense and 140g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 70r/min for 10min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at a speed of 70r/min for 3 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 2
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 55g of radix clematidis, 25g of divaricate saposhnikovia root, 22g of borneol, 32g of ligusticum wallichii, 15g of radix ranunculi ternati, 22g of erythrina bark, 27g of cyrtomium fortunei, 18g of garden balsam stem, 10g of pepper, 42g of artificial musk, 25g of raw nux vomica, 43g of fructus psoraleae, 35g of obscured homalomena rhizome, 20g of frankincense and 160g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 80r/min for 20min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at the speed of 80r/min for 5 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 3
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 60g of radix clematidis, 30g of divaricate saposhnikovia root, 22g of borneol, 36g of ligusticum wallichii, 20g of radix ranunculi ternati, 25g of erythrina bark, 30g of cyrtomium fortunei, 23g of garden balsam stem, 12g of pepper, 43g of artificial musk, 28g of raw nux vomica, 46g of fructus psoraleae, 38g of obscured homalomena rhizome, 25g of frankincense and 160g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 80r/min for 20min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at the speed of 80r/min for 5 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 4
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 70g of radix clematidis, 30g of divaricate saposhnikovia root, 30g of borneol, 40g of ligusticum wallichii, 25g of radix ranunculi ternati, 30g of erythrina bark, 40g of cyrtomium fortunei, 30g of garden balsam stem, 15g of pepper, 15g of artificial musk, 35g of raw nux vomica, 50g of fructus psoraleae, 40g of obscured homalomena rhizome, 35g of frankincense and 200g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 70r/min for 30min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at a speed of 80r/min for 3 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 5
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 50g of radix clematidis, 20g of divaricate saposhnikovia root, 20g of borneol, 30g of ligusticum wallichii, 10g of radix ranunculi ternati, 20g of erythrina bark, 25g of cyrtomium fortunei, 10g of garden balsam stem, 10g of pepper, 10g of Piper skinnum, 40g of artificial musk, 20g of raw nux vomica, 40g of fructus psoraleae, 30g of obscured homalomena rhizome, 15g of frankincense and 140g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, cortex moutan, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 70r/min for 30min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at a speed of 70r/min for 3 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 6
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 55g of radix clematidis, 25g of divaricate saposhnikovia root, 25g of borneol, 33g of ligusticum wallichii, 14g of radix ranunculi ternati, 25g of erythrina bark, 27g of cyrtomium fortunei, 22g of garden balsam stem, 15g of pepper, 20g of Piper nigrum, 45g of artificial musk, 25g of raw nux vomica, 42g of fructus psoraleae, 33g of obscured homalomena rhizome, 20g of frankincense and 150g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, cortex moutan, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 80r/min for 30min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at the speed of 80r/min for 5 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 7
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 60g of radix clematidis, 30g of divaricate saposhnikovia root, 22g of borneol, 36g of ligusticum wallichii, 20g of radix ranunculi ternati, 25g of erythrina bark, 30g of cyrtomium fortunei, 23g of garden balsam stem, 12g of pepper, 25g of Piper nigrum, 43g of artificial musk, 28g of raw nux vomica, 46g of fructus psoraleae, 38g of obscured homalomena rhizome, 25g of frankincense and 160g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, cortex moutan, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 80r/min for 30min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at the speed of 80r/min for 5 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 8
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 70g of radix clematidis, 30g of divaricate saposhnikovia root, 28g of borneol, 40g of ligusticum wallichii, 25g of radix ranunculi ternati, 30g of erythrina bark, 40g of cyrtomium fortunei, 25g of garden balsam stem, 15g of pepper, 30g of Piper nigrum, 48g of artificial musk, 35g of raw nux vomica, 50g of fructus psoraleae, 38g of obscured homalomena rhizome, 30g of frankincense and 180g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, cortex moutan, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 80r/min for 30min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at the speed of 80r/min for 5 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
And (3) counting clinical data:
the inventor of the present application treated 256 patients in total from 2008 to 2020. Among them, 86 cases of patients with cervical vertebra hyperosteogeny, 91 cases of patients with lumbar vertebra hyperosteogeny, 60 cases of patients with knee joint hyperosteogeny, 13 cases of patients with ankle joint hyperosteogeny, and 6 cases of patients with both lumbar joint hyperosteogeny and cervical vertebra hyperosteogeny. Wherein, 208 patients are cured, the cure rate reaches 81 percent, 27 patients are effectively relieved, and the total effective rate reaches 92 percent.
And (3) curing: the pathological symptoms disappear, the physiological function returns to normal, the reduction or elimination of the original hyperplastic tissues of the vertebral body or the bone joint is assisted to be checked, and the disease does not recur for more than half a year.
The method has the following advantages: pain, numbness or other pathological conditions are reduced, but their clinical manifestations are not completely eliminated.
Typical cases of clinical practice are as follows:
typical case 1: liu somebody, man, 45 years old, 3 months and 26 days in 2009 to see a doctor, 7 years long-term driving leads to waist gall, go to hospital to examine, and hospital X-ray diagnosis shows that waist hyperostosis, adopt the traditional Chinese medicine of this embodiment 3 to treat, paste this traditional Chinese medicine on the paster carrier, and paste this paster in the waist pain department, paste one day, paste 12h each time, 3 consecutive courses of treatment, 3 subsides of each course of treatment, 3 courses of treatment back waist are basically painless, resume normal.
Typical case 2: zhang a certain, the woman, 60 years old, 7 months 15 days of 2009 see a doctor, it is uncomfortable to have passed the age often cervical vertebra, go to the hospital inspection, it is cervical hyperostosis to diagnose through the doctor, adopt the traditional chinese medicine of this embodiment 7 to treat, paste this traditional chinese medicine on the paster carrier to paste this paster in the neck pain department, paste one day, paste 15h at every turn, 1 course of treatment is tried out earlier, it is effective to paste the back discovery, continue 2 courses of treatment, the effect is showing after 3 courses of treatment, can normal life.
Typical case 3: deng, a woman in 39 years old, and a doctor visits a doctor 5/3 days in 2010, and a long-term sitting office causes cervical vertebra pain, the doctor diagnoses the cervical vertebra hyperosteogeny, the traditional Chinese medicine prepared in the embodiment 6 is adopted for treatment, the traditional Chinese medicine is pasted on a patch carrier, the patch is pasted on the cervical part pain, the patch is pasted one day for 12 hours every time, the treatment lasts for 4 courses of treatment, the effect is remarkable, the cervical vertebra is basically improved, and no discomfort exists.
Typical case 4: in a forest, men, age 52, visit 8 months after 2013, are engaged in physical labor for a long time, and have pain in knee joints, the treatment is performed before introduction of acquaintances, the traditional Chinese medicine prepared in the embodiment 4 is adopted for treatment, the traditional Chinese medicine is pasted on a patch carrier, the patch is pasted on the pain part of the knee, the patch is pasted one day for 12 hours every time, the effect is remarkable, the knee joints are basically improved, the pain is basically avoided, and the normal dry work can be performed.
Typical case 5: zhao, a woman is 68 years old, and the woman has been treated in 2015 for 26 days, the treatment is retired, lumbar hyperosteogeny is caused due to overstrain in young age, many treatment sites are not cured, and the treatment is introduced by the mature people.
Typical case 6: wangzhi, male, 37 years old, visit 13 days 2 months in 2017, work on the building site for a long time, waist fatigue is excessive, lumbar hyperosteogeny is caused, medicine taking physical therapy is not improved, the treatment is introduced by the mature people, the traditional Chinese medicine prepared in the embodiment 7 is adopted for treatment, the traditional Chinese medicine is pasted on a patch carrier, the patch is pasted on a waist pain part one day, 15 hours are pasted every time, 3 courses of treatment are insisted, the effect is remarkable, the waist basically improves, the pain is basically avoided, and normal activities can be realized.
In conclusion, the traditional Chinese medicine prepared by the embodiment of the invention has an obvious effect on patients with hyperosteogeny, can relieve pain and has a better treatment effect, and because the components used in the adopted formula belong to relatively cheap medicinal materials, the treatment expense of the patients can be reduced.
The embodiments described above are some, but not all embodiments of the invention. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention as claimed, but is merely representative of selected embodiments of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Claims (10)
1. The traditional Chinese medicine for treating the hyperosteogeny is characterized by being prepared from the following raw medicines in parts by weight: 50-70 parts of clematis root, 20-30 parts of divaricate saposhnikovia root, 20-30 parts of borneol, 30-40 parts of szechuan lovage rhizome, 10-25 parts of ternate buttercup root, 20-30 parts of erythrina bark, 25-40 parts of cyrtomium rhizome, 10-30 parts of garden balsam stem, 10-15 parts of Sichuan pepper, 40-50 parts of artificial musk, 20-35 parts of raw nux vomica, 40-50 parts of malaytea scurfpea fruit, 30-40 parts of obscured homalomena rhizome, 15-35 parts of frankincense and 200 parts of white spirit 140 and other materials.
2. The traditional Chinese medicine for treating hyperosteogeny according to claim 1, which is prepared from the following raw material medicines in parts by weight: 60 parts of clematis root, 30 parts of divaricate saposhnikovia root, 22 parts of borneol, 36 parts of szechuan lovage rhizome, 20 parts of ternate buttercup root, 25 parts of erythrina bark, 30 parts of cyrtomium rhizome, 23 parts of garden balsam stem, 12 parts of pricklyash peel, 43 parts of artificial musk, 28 parts of raw nux vomica, 46 parts of malaytea scurfpea fruit, 38 parts of obscured homalomena rhizome, 25 parts of frankincense and 160 parts of white spirit.
3. The traditional Chinese medicine for treating hyperosteogeny according to claim 1, is characterized by being prepared from the following raw medicines in parts by weight: 50-70 parts of clematis root, 20-30 parts of divaricate saposhnikovia root, 20-30 parts of borneol, 30-40 parts of szechuan lovage rhizome, 10-25 parts of ternate buttercup root, 20-30 parts of erythrina bark, 25-40 parts of cyrtomium rhizome, 10-30 parts of garden balsam stem, 10-15 parts of Sichuan pepper, 10-30 parts of seed of Chinese wampee, 40-50 parts of artificial musk, 20-35 parts of raw nux vomica, 40-50 parts of malaytea scurfpea fruit, 30-40 parts of obscured homalomena rhizome, 15-35 parts of frankincense and 200 parts of white spirit.
4. The traditional Chinese medicine for treating hyperosteogeny according to claim 3, is characterized by being prepared from the following raw medicines in parts by weight: 60 parts of clematis root, 30 parts of divaricate saposhnikovia root, 22 parts of borneol, 36 parts of szechuan lovage rhizome, 20 parts of ternate buttercup root, 25 parts of erythrina bark, 30 parts of cyrtomium rhizome, 23 parts of garden balsam stem, 12 parts of pricklyash peel, 25 parts of seed of Chinese yam, 43 parts of artificial musk, 28 parts of raw nux vomica, 46 parts of malaytea scurfpea fruit, 38 parts of obscured homalomena rhizome, 25 parts of frankincense and 160 parts of white.
5. The traditional Chinese medicine for treating hyperosteogeny according to claim 1, wherein the white spirit is 60-65 alcohol.
6. A method for preparing the traditional Chinese medicine for treating hyperosteogeny according to any one of the claims 1 or 3, which comprises the following steps:
weighing the medicines: weighing the raw material medicines according to the proportion of the formula;
crushing: pulverizing the raw materials except Chinese liquor to obtain raw medicinal powder;
mixing: mixing the raw material powder obtained in the crushing step with the white spirit, and uniformly stirring to obtain a mixture;
sealing: placing the mixture prepared in the mixing step in a closed container for sealed storage;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
7. The method according to claim 6, wherein the raw materials are subjected to impurity removal, screening, washing, drying and baking before the crushing step.
8. The method for preparing a Chinese medicinal composition for treating hyperosteogeny according to claim 6, wherein the size of the raw material powder crushed in the crushing step is 80-200 meshes.
9. The method for preparing a Chinese medicinal composition for treating hyperosteogeny according to claim 6, wherein the mixing speed in the mixing step is 70-80r/min, and the mixing time is 10-30 min.
10. The method for preparing a Chinese medicinal composition for treating hyperosteogeny according to claim 6, wherein said sealing step comprises hermetically storing the mixture in a sealed container for 3 months, and stirring the mixture in the container at a speed of 70-80r/min for 1-5min by opening the container at 1-month intervals.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110034417.XA CN112603957A (en) | 2021-01-11 | 2021-01-11 | Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110034417.XA CN112603957A (en) | 2021-01-11 | 2021-01-11 | Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112603957A true CN112603957A (en) | 2021-04-06 |
Family
ID=75253851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110034417.XA Pending CN112603957A (en) | 2021-01-11 | 2021-01-11 | Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112603957A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1285196A (en) * | 2000-08-28 | 2001-02-28 | 赵芳可 | Shubi plaster for treating arthralgia due to wind-cold-dampness |
| CN101905007A (en) * | 2010-07-09 | 2010-12-08 | 徐利华 | Plaster for curing rheumatoid pains in neck, shoulders, waist and legs |
| CN102266541A (en) * | 2011-07-11 | 2011-12-07 | 谢书芳 | Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain |
-
2021
- 2021-01-11 CN CN202110034417.XA patent/CN112603957A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1285196A (en) * | 2000-08-28 | 2001-02-28 | 赵芳可 | Shubi plaster for treating arthralgia due to wind-cold-dampness |
| CN101905007A (en) * | 2010-07-09 | 2010-12-08 | 徐利华 | Plaster for curing rheumatoid pains in neck, shoulders, waist and legs |
| CN102266541A (en) * | 2011-07-11 | 2011-12-07 | 谢书芳 | Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain |
Non-Patent Citations (1)
| Title |
|---|
| 曹静: "消刺膏治疗骨质增生46例", 《中医外治杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104644943A (en) | Traditional Chinese medicine composition, medicinal moxibustion containing same and preparation method | |
| CN112915173A (en) | Traditional Chinese medicine composition for treating orthopedic diseases, preparation method and application | |
| CN112717103A (en) | Plant liquid for treating neck, shoulder, waist and leg pain | |
| CN115040574B (en) | Traditional Chinese medicine composition and traditional Chinese medicine preparation for treating thyroid nodule and preparation method thereof | |
| CN112603957A (en) | Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof | |
| CN104623432B (en) | A kind of Chinese medicine composition for treating tumour | |
| CN113082103A (en) | Traditional Chinese medicine composition for treating traumatic injury and sprain and preparation method thereof | |
| CN1054521C (en) | External use medicine bag for treatment of woman dysmenorrhea and its making method | |
| CN111419924A (en) | A topical Chinese medicinal composition for treating various muscle and bone diseases, and its preparation device | |
| CN113476577A (en) | A Chinese medicinal composition for treating rheumatic arthralgia and traumatic injury, and its preparation method | |
| CN111888450A (en) | Foot bath medicinal composition and preparation method for preventing and treating female cold stagnation and blood stasis dysmenorrhea | |
| CN117357608B (en) | External application medicine for treating traumatic injury and fracture and tendon injury | |
| CN110279746A (en) | A kind of massage cream and preparation method thereof for treating traumatic injury | |
| CN109847037A (en) | A kind of medicine-filled pillow and method for cure scapulohumeral periarthritis | |
| CN106729065A (en) | Fuling peel folium artemisiae argyi sweet basil moxibustion post | |
| CN121313746A (en) | Traditional Chinese medicine composition for promoting blood circulation to remove blood stasis and setting bones, application and use method thereof | |
| CN105560477A (en) | Meridian and collateral dredging hot compress salt and preparation method thereof | |
| CN116832102A (en) | Musk chain traditional Chinese medicine formula with wind-dispelling and cold-dispelling functions and preparation method thereof | |
| CN117562944A (en) | Medicine for treating lumbar paralysis | |
| CN115429844A (en) | Medicinal liquor for treating arthralgia | |
| CN115969948A (en) | Dampness-clearing navel plaster formula and preparation method thereof | |
| CN113797296A (en) | Agilawood moxa stick formula and preparation method | |
| CN112107669A (en) | A Chinese medicinal composition for treating arthritis and synovitis, and its preparation method | |
| CN113855752A (en) | A Chinese medicinal composition for treating osteoarticular diseases, and its preparation method | |
| CN114767775A (en) | External treatment of acute ankle sprain with traditional Chinese medicine composition, application and application of external treatment for tendon injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210406 |
|
| RJ01 | Rejection of invention patent application after publication |